• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GOVX

GOVX

GeoVax Labs, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.03

-0.07 (-3.33%)

Rating:C-

Company Profile

CEO

David Alan Dodd

IPO Date

2020-09-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.01

Prev. Close

$2.10

Day Low

$1.90

Day High

$2.08

52W Low

$0.96

52W High

$34.75

Market Cap

$0.00B

Volume

0.62M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

34.8%

Avg Negative

3.9%

Avg Neutral

61.5%

News Feed

GOVX Stock Increases Over 10% Intraday: Why It Happened

Pulse2·7/22/2021·↑ positive

GeoVax Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit

Newsfile Corp·5/11/2021·↑ positive

GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

GeoVax Spikes 80% On COVID-19 Research Grant Report

Benzinga·1/11/2021·↑ positive

GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·11/8/2020·↓ negative

GeoVax Labs, Inc.'s (GOVX) CEO David Dodd on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha·11/6/2020·↓ negative

GeoVax Reports 2020 Third Quarter Financial Results and Provides Corporate Update

GlobeNewsWire·11/5/2020·↑ positive

GeoVax to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update

GlobeNewsWire·10/30/2020·↓ negative

GeoVax CEO David Dodd to Participate in Virtual Webinar Hosted by Outsourced Pharma

GlobeNewsWire·10/28/2020·↑ positive

GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development

GlobeNewsWire·10/26/2020·↑ positive